Maxcyte inc (MXCT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MXCT Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Maxcyte inc manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent15.04
Short-term Investments, Total90.65
Cash & Short-term Investments105.00
Accounts receivable3.92
Inventories7.80
Prepaid Expense And Other Assets Current3.66
Total Current Assets121.27
Equipment/Property/Plant Net14.90
Goodwill net0.00
Intangible Assets0.77
Long-term investments36.23
Other Assets, Noncurrent11.50
Operating Lease Right Of Use Asset10.70
Total Assets184.67
Liabilities
Accounts Payable, Current AC1.73
Accrued Liabilities And Other Liabilities2.80
Other Liabilities, Current2.90
Deferred Revenue, Current DE2.46
Total Current Liabilities9.90
Total Long-term Debt0.00
Other liabilities, Noncurrent16.03
Operating Lease Liability Current1.37
Operating Lease Liability Noncurrent16.11
Total Liabilities25.92
Stockholders' Equity
Common Stock Value1.07
Additional Paid In Capital Common Stock434.26
Retained Earnings / Accumulated Deficit-275.11
Other Equity0.00
Common Stockholder's Equity158.75
Total Stockholder's Equity158.75
Liabilities & Stockholder's Equity184.67
4 historic quarters locked

Sign in to unlock the full Maxcyte inc balance sheet history.

About Maxcyte Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-095971

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.